Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells

Cancer Research

Volumn 61, Issue 7, 2001, Pages 3194-3199

  Fishman, D A ^a   Liu, Y ^a   Ellerbroek, S M ^a   Stack, M S ^a  

^a Interventional Radiology at la Grange Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; COLLAGEN TYPE 1; LYSOPHOSPHATIDIC ACID; MATRIX METALLOPROTEINASE;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD29; CELL ADHESION; CELL MOVEMENT; COLLAGEN; ENZYME ACTIVATION; ENZYME PRECURSORS; FEMALE; GELATINASES; HUMANS; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS;

EID: 0035300534     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Prospective on ovarian cancer: Why prevent?
2. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients
3. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
4. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid
5. Lysophosphatidic acid: G protein signaling and cellular responses
6. Lysophospholipids activate ovarian and breast cancer cells
7. Tyrosine phosphorylation is involved in reorganization of the actin cytoskeleton in response to serum or LPA stimulation
8. Synergism among lysophosphatidic acid, β1A integrins, and epidermal growth factor or platelet-derived growth factor in mediation of cell migration
9. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D
10. Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA)
11. The role of proteolytic enzymes in the pathology of ovarian carcinoma
12. 1 integrin
13. i 67 antigen in serious tumors of the ovary: A clinicopathologic, immunohistochemical, and serological study
14. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts
15. Matrix metalloproteinase inhibitors: A novel class of anti-cancer agents
16. A matrix metalloproteinase expressed on the surface of invasive tumor cells
17. The TIMP-2 membrane type 1 metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A
18. Proteolytic processing of membrane-type 1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
19. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells
20. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts
21. A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2
22. MT1-MMP on the cell surface causes focal degradation of gelatin films
23. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
24. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
25. A novel coumarin-labelled peptide for sensitive continuous assay of matrix metalloproteinases
26. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer
27. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer
28. Intercellular signaling by lysophosphatidate
29. 1 integrin
30. 1 integrin-mediated interaction with type I collagen
31. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix
32. The phagokinetic tracks of 3T3 cells
33. Shear stress enhances human endothelial cell wound closure in vitro
34. 1A integrins is required for lysophosphatidic acid-induced migration of β1 -null mouse fibroblastic cells
35. TIMP-2 promotes activation of progelatinase A by membrane type 1 matrix metalloproteinase immobilized on agarose beads
36. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
37. Contribution of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis
38. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate
39. Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner